Literature DB >> 16647341

Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.

Sam M Wiseman1, Hamid Masoudi, Paddy Niblock, Dmitry Turbin, Ashish Rajput, John Hay, Douglas Filipenko, David Huntsman, Blake Gilks.   

Abstract

BACKGROUND: Anaplastic thyroid cancer arises, or transforms, from pre-existing differentiated thyroid cancer. E-cadherin functions as a cell-cell adhesion molecule that complexes with catenin proteins for function. The objective of this study was to evaluate the change in E-cadherin/beta-catenin expression in the transformation of differentiated to anaplastic thyroid carcinoma.
METHODS: A tissue microarray was constructed from 12 anaplastic thyroid tumors and their adjacent associated differentiated foci. Immunohistochemistry was used to evaluate tumor expression of E-cadherin and beta-catenin.
RESULTS: There was decreased expression of E-cadherin and beta-catenin by the anaplastic tumors when compared with the differentiated thyroid tumors from which they evolved. The expression of E-cadherin and beta-catenin was 92% and 67%, respectively, by the differentiated thyroid carcinoma, and 17% and 50%, respectively, by the anaplastic tumors.
CONCLUSIONS: This report shows that derangement of the E-cadherin/catenin complex is associated with the transformation of differentiated into anaplastic thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647341     DOI: 10.1016/j.amjsurg.2006.02.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  17 in total

Review 1.  Anaplastic thyroid cancer, tumorigenesis and therapy.

Authors:  J P O'Neill; D Power; C Condron; D Bouchier-Hayes; M Walsh
Journal:  Ir J Med Sci       Date:  2009-08-07       Impact factor: 1.568

2.  E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.

Authors:  Liang Li; Zhe Zhang; Bin Li; Fei Gao; Liaoqing Li; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-08       Impact factor: 3.117

3.  Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Authors:  Darya Buehler; Heather Hardin; Weihua Shan; Celina Montemayor-Garcia; Patrick S Rush; Sofia Asioli; Herbert Chen; Ricardo V Lloyd
Journal:  Mod Pathol       Date:  2012-08-17       Impact factor: 7.842

4.  Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-10-01

Review 5.  Management of anaplastic thyroid cancer.

Authors:  Xavier M Keutgen; Samira M Sadowski; Electron Kebebew
Journal:  Gland Surg       Date:  2015-02

6.  Anaplastic transformation of differentiated thyroid carcinoma.

Authors:  Gamal Khairy
Journal:  Int J Health Sci (Qassim)       Date:  2009-01

7.  Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.

Authors:  J L Werbeck; N K Thudi; C K Martin; C Premanandan; L Yu; M C Ostrowksi; T J Rosol
Journal:  Vet Pathol       Date:  2013-10-03       Impact factor: 2.221

Review 8.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

9.  Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.

Authors:  Chang Won Jung; Kang Hee Han; Hyesil Seol; Sunhoo Park; Jae Soo Koh; Seung-Sook Lee; Min Joo Kim; Ik Joon Choi; Jae Kyung Myung
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 10.  Molecular markers of aggressiveness of thyroid cancer.

Authors:  Matthew D Ringel
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-10       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.